Deelnemers

Heb je een vraag? Neem gerust contact met ons op.

 

Telefoon: 050 - 36 11 113 (werkdagen van 8.00 - 17.00 uur)

Contactformulier

Researchers

Do you have a question regarding working with Lifelines? Please contact us, we're happy to help you.

Contact us

Pers

We voorzien media graag van informatie en we behandelen graag verzoeken voor interviews, opnames en beeldmateriaal.

Stuur een e-mail

Contact

LC-PUFA’s and mental health outcomes: the role of overall diet quality, genetic susceptibility and fatty fish intake

Fatty fish is a component of a healthy diet, and is included in dietary guidelines for both children/adolescents and adults. Dietary fatty fish provides long-chain poly-unsaturated fatty acids (LC-PUFA’s) that are important for brain development and brain functioning. LC-PUFA intake by means supplement use has been implicated in a wide range of beneficial mental health outcomes, including better cognitive performance in children after adequate maternal intake during pregnancy [1], reduction of inattention [2] and/or oppositional problems [3] in children and adolescents, reduction of depressive symptoms in adults [4], and better cognitive functioning in the elderly [5]. Unfortunately, there are a number of methodological problems with the available studies. Most importantly, clinical trials in small groups typically fail to replicate in larger samples. A Cochrane review on the role of LC-PUFA’s in depression found that the available evidence was of very low quality, and that there were strong indications for publication bias [6]. Observational studies of fatty fish intake rather than supplements are typically performed in larger samples, but those are mostly cross-sectional. Some find modest associations between LC-PUFA intake and mental health outcomes (e.g. [7][8]). However, most of these studies poorly address potential confounders, most importantly age, overall diet quality and socio-economic status.
The absence of strong associations between LC-PUFA intake and mental health outcomes at the group level may suggest individual differences: LC-PUFA intake might prove beneficial for some individuals, but not for others. In studies of diabetes [9], cardiovascular disease [10] and obesityrelated traits [11], LC-PUFA supplementation was shown to be beneficial in people carrying minor/variant alleles in the FADS1-2 and ELOVL2-5 gene clusters, but less so in people carrying the regular haplotypes. These effects are mediated by altered blood serum LC-PUFA levels, which are highly heritable [12]. FADS1-2 and ELOVL2-5 gene clusters code fatty acids desaturase  and elongase enzymes, that convert LA to DPA and EPA to DHA. Variants in these gene clusters have also been associated with depression [13], bipolar disorder [14], white matter development [15] and inflammatory diseases [16]. It is therefore interesting to investigate whether genetic risk score for serum LC-PUFA levels interact with LC-PUFA intake to determine mental health outcomes.

Year of approval

2020

Institute

UMCG - Interdisciplinary Center Psychopathology & Emotion regulation (ICPE)

Primary applicant

Hartman, C.